Crinetics Pharmaceuticals, Inc. (CRNX) › Shareholders' EquityCrinetics Pharmaceuticals, Inc. (CRNX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$463.0K2016: -$6.20M2017: -$15.02M2018: $160.22M2019: $117.14M2020: $168.92M2021: $331.94M2022: $316.33M2023: $539.11M2024: $1.32B2025: $992.08M$992.08M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$992.08M-25.1%2024$1.32B+145.7%2023$539.11M+70.4%2022$316.33M-4.7%2021$331.94M+96.5%2020$168.92M+44.2%2019$117.14M-26.9%2018$160.22M+1166.6%2017-$15.02M-142.1%2016-$6.20M-1240.0%2015-$463.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share